American Heart Journal
Volume 145, Issue 6 , Pages 941-942 , June 2003

Markers of inflammation and thrombosis: clues to plaque instability?

  • Iftikhar J. Kullo, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minn, USA
    • Corresponding Author InformationReprint requests: Iftikhar J. Kullo, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
    • ,
  • Bernard J. Gersh, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minn, USA

References 

  1. Davies MJ. Stability and instability (two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995). Circulation. 1996;94:2013–2020
  2. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44
  3. Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque (pathobiology and clinical implications). Ann Int Med. 1998;129:1050–1060
  4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  5. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565
  6. Liuzzo G, Biasucci LM, Gallimore JR, et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Eng J Med. 1994;331:417–424
  7. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group (Fragmin during Instability in Coronary Artery Disease). N Engl J Med. 2000;343:1139–1147
  8. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor (a meta-analysis and review of the literature). Ann Int Med. 1993;118:956–963
  9. Danesh J, Whincup P, Walker M, et al.  Fibrin d-dimer and coronary heart disease (prospective study and meta-analysis). Circulation. 2001;103:2323–2327
  10. Lowe GD, Rumley A. Use of fibrinogen and fibrin d-dimer in prediction of arterial thrombotic events. Thromb Haemost. 1999;82:667–672
  11. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (d-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90:2236–2240
  12. Menown IBA, Mathew TP, Gracey HM, et al. Prediction of recurrent events by D-dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) study. Am Heart J 2003;145:986–92
  13. Biasucci LM, Liuzzo G, Grillo RL, et al.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855–860
  14. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  15. Tracy RP. Epidemiological evidence for inflammation in cardiovascular disease. Thromb Haemost. 1999;82:826–831

PII: S0002-8703(03)00170-4

doi: 10.1016/S0002-8703(03)00170-4

American Heart Journal
Volume 145, Issue 6 , Pages 941-942 , June 2003

Article Tools